BXN 11.8% 1.9¢ bioxyne limited

Ann: Positive Bioxyne Gut Health Clinical Trial Results, page-17

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 61,011 Posts.
    lightbulb Created with Sketch. 31
    Just had a friend die within 2 weeks of his diagnosis of serious stomach cancer so welcome any new drug of this nature. That type of diagnosis freaks me out and so does his death still. You could not have even imagined the scenario occurring.

    Positive Bioxyne Gut Health Clinical Trial Results
    Highlights

    • Initial results from the completed clinical trial examining the effects on microbiome composition, gastrointestinal symptoms, quality of life, medication use and adverse events were received. • The substantial amount of generated data is in the process of being analysed and peer reviewed. A comprehensive analysis is expected in early 2018. • Significant beneficial effects were observed in reductions of a range of gastric symptoms including bloating and gas, and significantly less antibiotic use during the study period.
    Last edited by Goblin: 11/12/17
 
watchlist Created with Sketch. Add BXN (ASX) to my watchlist
(20min delay)
Last
1.9¢
Change
0.002(11.8%)
Mkt cap ! $26.60M
Open High Low Value Volume
1.8¢ 1.9¢ 1.8¢ $29.15K 1.552M

Buyers (Bids)

No. Vol. Price($)
1 256684 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 500000 1
View Market Depth
Last trade - 12.40pm 04/12/2024 (20 minute delay) ?
BXN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.